Finjan's IP Not Worth $5M, Patent Case Jury Is Told
Cybersecurity firm Sophos called experts to testify in California federal court Wednesday that its anti-virus software differs from technology described in rival Finjan's patents and that, even if it had infringed...To view the full article, register now.
Already a subscriber? Click here to view full article